AVGO: the bull case, the bear case, and the verdict
Why the screener flagged it
- Low PEG ratio
- Unusual volume surge
- Revenue growth accelerating
- Breakout above 50-day average
The bull case
I appreciate the opportunity to make a strong case for AVGO, especially given the mixed sentiment and recent volatility we've seen this week. Let me address what I believe is a compelling bull thesis, then tackle the bearish arguments head-on with evidence-based reasoning.
Before I engage with bear arguments, let me establish the foundational case:
1. The scale of the AI capex opportunity is underestimated
Look at the numbers objectively:
- Q3 2026 revenue: $29.59B (up 85% YoY from $15.95B)
- Q3 2026 net income: $13.09B (up 216% YoY from $4.14B)
- Forward EPS guidance: $19.47 (149% growth from TTM $7.83)
This isn't a marginal improvement—this is exponential acceleration. And here's the critical point: AVGO's products are non-negotiable infrastructure. When hyperscalers (Google, Meta, Amazon, Microsoft) deploy AI accelerators, they need:
- High-bandwidth interconnect (Broadcom's custom silicon specialty)
- Optical networking infrastructure
- Data center switching and routing
- Custom networking solutions
These aren't optional components—they're the plumbing that makes AI systems work. You can't build an AI data center without Broadcom's connectivity solutions.
Continues in the full debate transcript — unlock Pro ($39/mo or $379/yr) →
The bear case
I appreciate the bull's comprehensive argument, but it fundamentally misdiagnoses the risks while cherry-picking favorable data points. Let me dismantle the core bull thesis systematically and expose the dangerous assumptions embedded in this investment case.
Executive summary: the house of cards
The bull case rests on three critical assumptions that are rapidly deteriorating:
- Hyperscaler capex will remain elevated through 2027-2028 — The data suggests otherwise
- AVGO's customer concentration is "bullish" — This is a dangerous rationalization of structural risk
- Forward valuation of 18.7x P/E is "reasonable" — It's actually aggressive relative to historical cycles
I'm going to systematically demolish each pillar of the bull argument, then present the bear thesis that the market will soon embrace: AVGO is a value-destroying acquisition at $364 that peaked at $495 for good reasons, and is heading back to $280-320 within 12 months.
Problem #1: the bull confuses extrapolation with analysis
The 85% Revenue Growth is a Red Flag, Not a Green Light
The bull presents Q3 2026 revenue growth of 85% YoY as proof that the capex cycle is sustainable. This is the exact opposite of what history teaches us.
Continues in the full debate transcript — unlock Pro ($39/mo or $379/yr) →
The research manager's call
Recommendation: Overweight
Rationale: This was a genuinely well-argued debate on both sides, but after weighing the evidence carefully, the bull's case carries the edge for the next 3 months (63 trading days).
Where the bull won decisively
- Valuation on a forward basis is not stretched. The bear's most damaging counter — that "real PEG is 3.9x using 12% growth" — is a circular argument. The bear assumes growth decelerates to 12% and then uses that assumption to prove the stock is expensive. But there is no concrete evidence yet that AVGO's growth has fallen to 12%. The company just reported 85% YoY revenue growth and guided to forward EPS of $19.47 (implying ~149% growth). Until actual numbers confirm deceleration, analysts and the market will anchor on the guidance, not the bear's hypothetical. At 18.7x forward P/E with strong near-term earnings visibility, the valuation is competitive versus the S&P 500 — not a reason to underperform.
- The debt picture is genuinely strong right now. Net debt fell $18.1B in 12 months; coverage is 8.6x; the 0.7x Net Debt/EBITDA is healthy. The bear's scenario where FCF drops to $10-12B is plausible over 18-24 months, but over a 3-month horizon, this is a non-event. No imminent debt stress.
- Near-term catalysts are bullish. Hyperscaler earnings season (Google, Meta, Amazon) in December/January is the next major event. All three have been signaling continued aggressive AI capex publicly and recently. If even two of three maintain or raise capex guidance, AVGO's forward estimates get revised up, not down. The bear's scenario requires these companies to signal moderation — there is no current evidence they will do so within the 63-day window.
Continues in the full debate transcript — unlock Pro ($39/mo or $379/yr) →
Stress-test your own thesis on AVGO (or any US stock)
Enter a ticker, your optional thesis, and your email. Twelve AI agents will argue the bull and bear case, test your reasoning, and email your 4-page PDF report.
Unlock the full trade plan & Trader desk
Stop loss and take profit levels, position sizing, the risk team's debate and the full transcript for AVGO are in Pro ($39/mo or $379/yr, 5/day). Or upgrade to Trader ($99/mo or $949/yr, 10/day) for live position tracking vs the S&P 500, price/stop email alerts, and weekly Monday AI thesis re-checks. Pro and Trader both include an Alpaca paper-trading order ticket.
Get Pro — $39/mo →Get Trader — $99/mo →5-Report Pack — $19 one-time →Founding Lifetime Pass — $499 (20 seats) →All AVGO debates and the latest verdict →
Other recent analyses
This page was generated automatically by HedgePick's AI agents from public market data. It is general information, not personalized investment advice, and not a recommendation to buy or sell any security. AI output can be wrong or out of date. HedgePick is not a registered investment adviser or broker-dealer. Do your own research and consider your own situation before trading.